Longitudinal growth occurs within the long bones at the growth plate. During childhood, the growth plate matures, its total width decreases and eventually it disappears at the end of puberty with complete replacement by bone along with cessation of longitudinal growth. The exact mechanism of epiphyseal fusion is still not completely understood and experimental studies are complicated by the fact that there is a species difference between humans and rabbits that do fuse their growth plates and rodents that do not. This mini review summarizes hypotheses and theories postulated in the literature regarding growth plate maturation and epiphyseal fusion. Growth factors, local regulators and hormones involved in growth plate maturation are described as well as four postulated hypotheses and theories regarding the final steps in epiphyseal fusion: apoptosis, autophagy, transdifferentiation and hypoxia. A better insight into the mechanisms of epiphyseal fusion may ultimately help to develop new strategies for the treatment of cartilage and growth disorders.

Keywords:
Cartilage disorder, Growth disorder, Epiphyseal fusion, Growth plate maturation
1.
Kronenberg HM: Developmental regulation of the growth plate. Nature 2003;423:332–336.
2.
Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, Antoniazzi F, Berenbaum S, Bourguignon JP, Chrousos GP, Coste J, Deal S, de Vries L, Foster C, Heger S, Holland J, Jahnukainen K, Juul A, Kaplowitz P, Lahlou N, Lee MM, Lee P, Merke DP, Neely EK, Oostdijk W, Phillip M, Rosenfield RL, Shulman D, Styne D, Tauber M, Wit JM: Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 2009;123:e752–e762.
3.
van der Eerden BC, Gevers EF, Lowik CW, Karperien M, Wit JM: Expression of estrogen receptor alpha and beta in the epiphyseal plate of the rat. Bone 2002;30:478–485.
4.
Karp SJ, Schipani E, St-Jacques B, Hunzelman J, Kronenberg H, McMahon AP: Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways. Development 2000;127:543–548.
5.
van der Eerden BC, Karperien M, Gevers EF, Lowik CW, Wit JM: Expression of Indian hedgehog, parathyroid hormone-related protein, and their receptors in the postnatal growth plate of the rat: evidence for a locally acting growth restraining feedback loop after birth. J Bone Miner Res 2000;15:1045–1055.
6.
Kindblom JM, Nilsson O, Hurme T, Ohlsson C, Savendahl L: Expression and localization of Indian hedgehog (Ihh) and parathyroid hormone related protein (PTHrP) in the human growth plate during pubertal development. J Endocrinol 2002;174:R1–R6.
7.
Hirai T, Chagin AS, Kobayashi T, Mackem S, Kronenberg HM: Parathyroid hormone/parathyroid hormone-related protein receptor signaling is required for maintenance of the growth plate in postnatal life. Proc Natl Acad Sci USA 2011;108:191–196.
8.
Hellemans J, Coucke PJ, Giedion A, De Paepe A, Kramer P, Beemer F, Mortier GR: Homozygous mutations in IHH cause acrocapitofemoral dysplasia, an autosomal recessive disorder with cone-shaped epiphyses in hands and hips. Am J Hum Genet 2003;72:1040–1046.
9.
Maeda Y, Nakamura E, Nguyen MT, Suva LJ, Swain FL, Razzaque MS, Mackem S, Lanske B: Indian hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc Natl Acad Sci USA 2007;104:6382–6387.
10.
Chiang C, Litingtung Y, Lee E, Young KE, Corden JL, Westphal H, Beachy PA: Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 1996;383:407–413.
11.
Tavella S, Biticchi R, Schito A, Minina E, Di Martino D, Pagano A, Vortkamp A, Horton WA, Cancedda R, Garofalo S: Targeted expression of SHH affects chondrocyte differentiation, growth plate organization, and Sox9 expression. J Bone Miner Res 2004;19:1678–1688.
12.
Schipani E, Lanske B, Hunzelman J, Luz A, Kovacs CS, Lee K, Pirro A, Kronenberg HM, Juppner H: Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc Natl Acad Sci USA 1997;94:13689–13694.
13.
Jobert AS, Zhang P, Couvineau A, Bonaventure J, Roume J, Le Merrer M, Silve C: Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest 1998;102:34–40.
14.
Yoshida CA, Komori T: Role of Runx proteins in chondrogenesis. Crit Rev Eukaryot Gene Expr 2005;15:243–254.
15.
Yoshida CA, Yamamoto H, Fujita T, Furuichi T, Ito K, Inoue K, Yamana K, Zanma A, Takada K, Ito Y, Komori T: Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev 2004;18:952–963.
16.
Leboy P, Grasso-Knight G, D’Angelo M, Volk SW, Lian JV, Drissi H, Stein GS, Adams SL: Smad-Runx interactions during chondrocyte maturation. J Bone Joint Surg Am 2001;83-A(suppl 1):S15–S22.
17.
Ballock RT, Heydemann A, Wakefield LM, Flanders KC, Roberts AB, Sporn MB: TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteases. Dev Biol 1993;158:414–429.
18.
Emons J, Chagin AS, Malmlof T, Lekman M, Tivesten A, Ohlsson C, Wit JM, Karperien M, Savendahl L: Expression of vascular endothelial growth factor in the growth plate is stimulated by estradiol and increases during pubertal development. J Endocrinol 2010;205:61–68.
19.
Maes C, Goossens S, Bartunkova S, Drogat B, Coenegrachts L, Stockmans I, Moermans K, Nyabi O, Haigh K, Naessens M, Haenebalcke L, Tuckermann JP, Tjwa M, Carmeliet P, Mandic V, David JP, Behrens A, Nagy A, Carmeliet G, Haigh JJ: Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bones. EMBO J 2010;29:424–441.
20.
Dean DD, Boyan BD, Schwart Z, Muniz OE, Carreno MR, Maeda S, Howell DS: Effect of 1alpha,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 on metalloproteinase activity and cell maturation in growth plate cartilage in vivo. Endocrine 2001;14:311–323.
21.
Donohue MM, Demay MB: Rickets in VDR null mice is secondary to decreased apoptosis of hypertrophic chondrocytes. Endocrinology 2002;143:3691–3694.
22.
Boyan BD, Sylvia VL, Dean DD, Del Toro F, Schwartz Z: Differential regulation of growth plate chondrocytes by 1alpha,25-(OH)2D3 and 24R,25-(OH)2D3 involves cell-maturation-specific membrane-receptor-activated phospholipid metabolism. Crit Rev Oral Biol Med 2002;13:143–154.
23.
Schwartz Z, Pedrozo HA, Sylvia VL, Gomez R, Dean DD, Boyan BD: 1alpha,25-(OH)2D3 regulates 25-hydroxyvitamin D3 24R-hydroxylase activity in growth zone costochondral growth plate chondrocytes via protein kinase C. Calcif Tissue Int 2001;69:365–372.
24.
Hugel U, Weber L, Reichrath J, Mehls O, Klaus G: Rat growth plate chondrocytes express low levels of 25-hydroxy-1alpha-hydroxylase. J Steroid Biochem Mol Biol 2004;89–90:143–147.
25.
Klaus G, von EB, May T, Hugel U, Mayer H, Ritz E, Mehls O: Synergistic effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on proliferation and vitamin D receptor expression of rat growth cartilage cells. Endocrinology 1994;135:1307–1315.
26.
Nilsson O, Parker EA, Hegde A, Chau M, Barnes KM, Baron J: Gradients in bone morphogenetic protein-related gene expression across the growth plate. J Endocrinol 2007;193:75–84.
27.
Pizette S, Niswander L: BMPs are required at two steps of limb chondrogenesis: formation of prechondrogenic condensations and their differentiation into chondrocytes. Dev Biol 2000;219:237–249.
28.
Minina E, Wenzel HM, Kreschel C, Karp S, Gaffield W, McMahon AP, Vortkamp A: BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development 2001;128:4523–4534.
29.
Yates KE, Shortkroff S, Reish RG: Wnt influence on chondrocyte differentiation and cartilage function. DNA Cell Biol 2005;24:446–457.
30.
Crowe R, Zikherman J, Niswander L: Delta-1 negatively regulates the transition from prehypertrophic to hypertrophic chondrocytes during cartilage formation. Development 1999;126:987–998.
31.
Minina E, Kreschel C, Naski MC, Ornitz DM, Vortkamp A: Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev Cell 2002;3:439–449.
32.
Lazarus JE, Hegde A, Andrade AC, Nilsson O, Baron J: Fibroblast growth factor expression in the postnatal growth plate. Bone 2007;40:577–586.
33.
Shiang R, Thompson LM, Zhu YZ, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ: Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994;78:335–342.
34.
Pannier S, Mugniery E, Jonquoy A, Benoist-Lasselin C, Odent T, Jais JP, Munnich A, Legeai-Mallet L: Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia. Bone 2010;47:905–915.
35.
Toydemir RM, Brassington AE, Bayrak-Toydemir P, Krakowiak PA, Jorde LB, Whitby FG, Longo N, Viskochil DH, Carey JC, Bamshad MJ: A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome. Am J Hum Genet 2006;79:935–941.
36.
Carel JC, Lahlou N, Roger M, Chaussain JL: Precocious puberty and statural growth. Hum Reprod Update 2004;10:135–147.
37.
Sedlmeyer IL, Palmert MR: Delayed puberty: analysis of a large case series from an academic center. J Clin Endocrinol Metab 2002;87:1613–1620.
38.
Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331:1056–1061.
39.
Borjesson AE, Lagerquist MK, Liu C, Shao R, Windahl SH, Karlsson C, Sjogren K, Movérare-Skrtic S, Antal MC, Krust A, Mohan S, Chambon P, Savendahl L, Ohlsson C: The role of estrogen receptor alpha in growth plate cartilage for longitudinal bone growth. J Bone Miner Res 2010;25:2414–2424.
40.
Chagin AS, Savendahl L: GPR30 estrogen receptor expression in the growth plate declines as puberty progresses. J Clin Endocrinol Metab 2007;92:4873–4877.
41.
Windahl SH, Andersson N, Chagin AS, Martensson UE, Carlsten H, Olde B, Swanson C, Movérare-Skrtic S, Savendahl L, Lagerquist MK, Leeb-Lundberg LM, Ohlsson C: The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice. Am J Physiol Endocrinol Metab 2009;296:E490–E496.
42.
Oz OK, Millsaps R, Welch R, Birch J, Zerwekh JE: Expression of aromatase in the human growth plate. J Mol Endocrinol 2001;27:249–253.
43.
van der Eerden BC, Lowik CW, Wit JM, Karperien M: Expression of estrogen receptors and enzymes involved in sex steroid metabolism in the rat tibia during sexual maturation. J Endocrinol 2004;180:457–467.
44.
Jansson JO, Eden S, Isaksson O: Sites of action of testosterone and estradiol on longitudinal bone growth. Am J Physiol 1983;244:E135–E140.
45.
Nilsson O, Chrysis D, Pajulo O, Boman A, Holst M, Rubinstein J, Martin RE, Savendahl L: Localization of estrogen receptors-alpha and -beta and androgen receptor in the human growth plate at different pubertal stages. J Endocrinol 2003;177:319–326.
46.
Ren SG, Malozowski S, Sanchez P, Sweet DE, Loriaux DL, Cassorla F: Direct administration of testosterone increases rat tibial epiphyseal growth plate width. Acta Endocrinol (Copenh) 1989;121:401–405.
47.
Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M, Smith ER: Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J Clin Endocrinol Metab 1993;76:996–1001.
48.
Maor G, Segev Y, Phillip M: Testosterone stimulates insulin-like growth factor-I and insulin-like growth factor-I-receptor gene expression in the mandibular condyle – a model of endochondral ossification. Endocrinology 1999;140:1901–1910.
49.
Coutant R, de Casson FB, Rouleau S, Douay O, Mathieu E, Gatelais F, Bouhours-Nouet N, Voinot C, Audran M, Limal JM: Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents. J Clin Endocrinol Metab 2004;89:6185–6192.
50.
Paspaliaris V, Petersen DN, Thiede MA: Steroid regulation of parathyroid hormone-related protein expression and action in the rat uterus. J Steroid Biochem Mol Biol 1995;53:259–265.
51.
Veldhuis JD, Keenan DM, Bailey JN, Adeniji A, Miles JM, Paulo R, Cosma M, Soares-Welch C: Estradiol supplementation in postmenopausal women attenuates suppression of pulsatile growth hormone secretion by recombinant human insulin-like growth factor type I. J Clin Endocrinol Metab 2008;93:4471–4478.
52.
Perry RJ, Farquharson C, Ahmed SF: The role of sex steroids in controlling pubertal growth. Clin Endocrinol (Oxf) 2008;68:4–15.
53.
de Zegher F, Butenandt O, Chatelain P, Albertsson-Wikland K, Jonsson B, Lofstrom A, Chaussain JL: Growth hormone treatment of short children born small for gestational age: reappraisal of the rate of bone maturation over 2 years and metanalysis of height gain over 4 years. Acta Paediatr Suppl 1997;423:207–212.
54.
Kamp GA, Waelkens JJ, de Muinck Keizer-Schrama SM, Delemarre-van de Waal HA, Verhoeven-Wind L, Zwinderman AH, Wit JM: High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature. Arch Dis Child 2002;87:215–220.
55.
Werther GA, Haynes K, Edmonson S, Oakes S, Buchanan CJ, Herington AC, Waters MJ: Identification of growth hormone receptors on human growth plate chondrocytes. Acta Paediatr Suppl 1993;82(suppl 391):50–53.
56.
Weise M, De Levi S, Barnes KM, Gafni RI, Abad V, Baron J: Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci USA 2001;98:6871–6876.
57.
Stevens DG, Boyer MI, Bowen CV: Transplantation of epiphyseal plate allografts between animals of different ages. J Pediatr Orthop 1999;19:398–403.
58.
Schrier L, Ferns SP, Barnes KM, Emons JA, Newman EI, Nilsson O, Baron J: Depletion of resting zone chondrocytes during growth plate senescence. J Endocrinol 2006;189:27–36.
59.
Lui JC, Chen W, Barnes KM, Baron J: Changes in gene expression associated with aging commonly originate during juvenile growth. Mech Ageing Dev 2010;131:641–649.
60.
Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER: Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997;337:91–95.
61.
Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B: The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 2002;16:2813–2828.
62.
Chrysis D, Nilsson O, Ritzen EM, Savendahl L: Apoptosis is developmentally regulated in rat growth plate. Endocrine 2002;18:271–278.
63.
Ahmed YA, Tatarczuch L, Pagel CN, Davies HM, Mirams M, Mackie EJ: Physiological death of hypertrophic chondrocytes. Osteoarthritis Cartilage 2007;15:575–586.
64.
Cohen JJ: Apoptosis. Immunol Today 1993;14:126–130.
65.
Roach HI, Clarke NM: Physiological cell death of chondrocytes in vivo is not confined to apoptosis. New observations on the mammalian growth plate. J Bone Joint Surg Br 2000;82:601–613.
66.
Emons J, Chagin AS, Hultenby K, Zhivotovsky B, Wit JM, Karperien M, Savendahl L: Epiphyseal fusion in the human growth plate does not involve classical apoptosis. Pediatr Res 2009;66:654–659.
67.
Roach HI, Clarke NM: ‘Cell paralysis’ as an intermediate stage in the programmed cell death of epiphyseal chondrocytes during development. J Bone Miner Res 1999;14:1367–1378.
68.
Roach HI, Clarke NM: Physiological cell death of chondrocytes in vivo is not confined to apoptosis. New observations on the mammalian growth plate. J Bone Joint Surg Br 2000;82:601–613.
69.
Roach HI, Aigner T, Kouri JB: Chondroptosis: a variant of apoptotic cell death in chondrocytes? Apoptosis 2004;9:265–277.
70.
Settembre C, rteaga-Solis E, McKee MD, de PR, Al AQ, Ballabio A, Karsenty G: Proteoglycan desulfation determines the efficiency of chondrocyte autophagy and the extent of FGF signaling during endochondral ossification. Genes Dev 2008;22:2645–2650.
71.
Shapiro IM, Adams CS, Freeman T, Srinivas V: Fate of the hypertrophic chondrocyte: microenvironmental perspectives on apoptosis and survival in the epiphyseal growth plate. Birth Defects Res C Embryo Today 2005;75:330–339.
72.
Roach HI, Aigner T, Kouri JB: Chondroptosis: a variant of apoptotic cell death in chondrocytes? Apoptosis 2004;9:265–277.
73.
Moskalewski S, Malejczyk J: Bone formation following intrarenal transplantation of isolated murine chondrocytes: chondrocyte-bone cell transdifferentiation? Development 1989;107:473–480.
74.
Groot CG, Thesingh CW, Wassenaar AM, Scherft JP: Osteoblasts develop from isolated fetal mouse chondrocytes when co-cultured in high density with brain tissue. In Vitro Cell Dev Biol Anim 1994;30A:547–554.
75.
Adams CS, Shapiro IM: The fate of the terminally differentiated chondrocyte: evidence for microenvironmental regulation of chondrocyte apoptosis. Crit Rev Oral Biol Med 2002;13:465–473.
76.
Horton WA, Dwyer C, Goering R, Dean DC: Immunohistochemistry of types I and II collagen in undecalcified skeletal tissues. J Histochem Cytochem 1983;31:417–425.
77.
White JR, Wilsman NJ, Leiferman EM, Noonan KJ: Histomorphometric analysis of an adolescent distal tibial physis prior to growth plate closure. J Child Orthop 2008;2:315–319.
78.
Stewart AJ, Houston B, Farquharson C: Elevated expression of hypoxia inducible factor-2alpha in terminally differentiating growth plate chondrocytes. J Cell Physiol 2006;206:435–440.
79.
Scortegagna M, Ding K, Oktay Y, Gaur A, Thurmond F, Yan LJ, Marck BT, Matsumoto AM, Shelton JM, Richardson JA, Bennett MJ, Garcia JA: Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1–/– mice. Nat Genet 2003;35:331–340.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.